Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-11759462-B2 United States of America 19 Sep 2023
Dosage regime and method for treating pulmonary arterial hypertension Grant US-11607413-B2 United States of America 21 Mar 2023
Crystalline spirocyclic compound, a dosage form containing, a method for using in… Grant US-11203597-B2 United States of America 21 Dec 2021
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-10946018-B2 United States of America 16 Mar 2021
Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and… Grant US-10710948-B2 United States of America 14 Jul 2020
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-10660893-B2 United States of America 26 May 2020
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-10350208-B2 United States of America 16 Jul 2019
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-10045988-B2 United States of America 14 Aug 2018
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-9750740-B2 United States of America 05 Sep 2017
Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1… Grant US-9611201-B2 United States of America 04 Apr 2017
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-9512122-B2 United States of America 06 Dec 2016
Spirocyclic compounds as tryptophan hydroxylase inhibitors Grant US-9199994-B2 United States of America 01 Dec 2015